In partnership with the Pharmaceutical Society of Australia (PSA), Quit has developed online training for pharmacists to support the development of knowledge and skills to confidently provide smoking cessation care. There are two modules.
Module: Smoking Cessation Brief Advice Training for Pharmacists
The ‘Smoking Cessation Brief Advice Training for Pharmacists’ module is designed to support smoking cessation care in pharmacy. It will equip pharmacists with the skills, confidence and knowledge to provide smoking cessation brief advice to patients who smoke.
This activity has been accredited by the PSA for 1.5 hours of Group 1 CPD (or 1.5 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 1.5 hours of Group 2 CPD (or 3 CPD credits) upon successful completion of relevant assessment activities.
This education has been approved as a Lung Learning Quality-Assured Activity.
Duration: 90 minutes
Cost: Free
Learning objectives:
- Describe evidence-based smoking cessation care
- Explain the pharmacist’s role in smoking cessation, including the importance of implementing the three-step smoking cessation brief advice (Ask, Advise, Help; AAH) model of care
- Explain the important role of multi-sessional behavioural intervention for smoking cessation (e.g. through Quitline) and describe how to refer patients
- Explain how to assess nicotine dependence and recognise the signs of nicotine withdrawal
- Describe the different pharmacotherapy options including clinical considerations and practice points
- Identify and manage clinically significant drug interactions associated with stopping smoking
Module: Pharmacists delivering nicotine dependence treatment under vaping reforms
The ‘Pharmacists delivering nicotine dependence treatment under vaping reforms’ online training module is designed to support pharmacists on the new regulatory framework introduced by the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024. It will equip pharmacists to recognise various vape types, understand evidence for smoking cessation, and navigate the updated supply process, ensuring their practice remains compliant and patient-centred.
This activity has been accredited by the PSA for 1 hour of Group 1 CPD (or 1 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 1 hour of Group 2 CPD (or 2 CPD credits) upon successful completion of relevant assessment activities.
Duration: 60 minutes
Cost: Free
Learning objectives:
- Recognise different compositions, features and systems of therapeutic vapes
- Discuss the evidence for the use of therapeutic vapes for smoking cessation
- Describe the process of accessing therapeutic vapes in Australia
- Describe the process of supplying therapeutic vapes.
Last updated: 13 November 2024